Access 5 Verified Employees Profiles for Canimguide TherapeuticsUnlock Free Contacts Now
About
CanImGuide is developing a therapeutic platform based around an extraordinary biologic concept and an entirely new mechanism of action for immunomodulation. They have discovered and thoroughly demonstrated, that a previously unknown immunosuppressive peptide named P3028 is formed in malignant tumors through the breakdown of albumin. This intra-tumoral albumin peptide binds to the fundamental receptor.